Конгресс 2014
Первая пятница декабря
Новости офтальмологии
Именно в этом номере можно будет прочитать полную программу Конгресса Российского глаукомного общества! Ждем!
The FDA is requiring Kala Pharmaceuticals to complete an additional clinical trial of KPI-121 0.25%, its candidate for the temporary relief of dry eye signs and symptoms, according to a press release.
Ocular surface disease (OSD) encompasses several disorders which include dry eye disease, blepharitis, meibomian gland dysfunction, ocular allergy, and conjunctivitis. Accurate diagnosis of OSD is characteristically challenging, as patients may present with more than one concurrent condition with substantial overlap of signs and symptoms. Therefore, OSD is frequently misdiagnosed and subsequently undertreated. In this CME activity, experts in the field will assess therapeutic strategies for optimal management of OSD as well as the different approaches for monitoring treatment response. The presentation of case studies will further provide tools to integrate treatment and monitoring pearls into practice.
Скоро она будет размещена в сети, и конечно же в бюллетене Новости глаукомы (№4, 2019, осень)
Immunocore Limited yesterday presented new biomarker research data for effects of Tebentafusp (IMCgp100) on patients with advanced uveal and cutaneous melanoma. Monotherapy treatment with the first-in-class ImmTAC® molecule tebentafusp was found to induce an immunologically potent response in patients. These findings, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, provide additional insight into the mechanism of action of tebentafusp in patients with advanced melanoma and demonstrates the potential association with clinical outcomes.
Purpose: The aim of this study was to evaluate the influence of four different types of speculums on aberrometry reading (OPD SCAN III [OPD]) and on intraoperative aberrometry reading (optiwave response analyzer, ORA).
Скоро подписчики его получат! А авторов приглашаем к сотрудничеству!
Dr Kenneth Fong (Sunway Medical Center – Malaysia) explains the interest of 577nm SubLiminal laser in the treatment of DME (видео)
Приказ Министерства здравоохранения РФ от 28 февраля 2019 г. № 103н "Об утверждении порядка и сроков разработки клинических рекомендаций, их пересмотра, типовой формы клинических рекомендаций и требований к их структуре, составу и научной обоснованности включаемой в клинические рекомендации информации”.
ANTERION® – the multimodal imaging platform optimized for the anterior segment – provides a high-resolution visualization of the entire anterior segment, from the anterior surface of the cornea to the posterior surface of the lens. ANTERION delivers revealing swept-source OCT images that provide visual confirmation and add reliability to the diagnosis and follow-up of anterior segment alterations.
Natsuko Mori,1,2 Hideaki Yokogawa,1 Akira Kobayashi,1 Tsubasa Nishino,1,3 Kazuhisa Sugiyama1 1Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; 2Department of Ophthalmology, Saiseikai Kanazawa Hospital, Kanazawa, Japan; 3Department of Ophthalmology, Toyama Prefectural Central Hospital, Toyama, Japan Purpose: This study aimed to elucidate the frequency of surgery-induced iris abnormalities after Descemet membrane endothelial keratoplasty (DMEK) and their impact on postoperative clinical outcomes.
Evidence from randomized controlled trials supports the use of two less invasive glaucoma treatment options, selective laser trabeculoplasty and a microstent. By Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed); and Keith Barton, MD, FRCP, FRCS
Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser has been announced as the approved delivery device for Bausch+Lomb’s Levofree Multidose in France. This marks the first approval by the French National Agency for Medicines and Health Products Safety (ANSM) for Aptar Pharma’s Ophthalmic Dispenser.
Программа круглого стола "Актуальные вопросы офтальмологии. Приверженность к лечению больных с глаукомой", 20 сентября 2019 года
ABSTRACT SUMMARY In this observational case-controlled study, investigators used OCT angiography to evaluate microvascular perfusion in the optic nerve head region of glaucomatous eyes with or without disc hemorrhage (DH). The researchers also studied the relationship between parapapillary choroidal microvascular dropout (MVD) and retinal nerve fiber layer (RNFL) thickness. The study included 82 eyes with open-angle glaucoma (OAG) and DH and 68 OAG eyes without DH, all of which had at least four serial OCT angiography examinations. Outcome measures included MVD detection rate, extent of MVD, and RNFL thinning rate. MVD was defined as complete loss of microvasculature within the choroidal layer of the parapapillary region.
"Want to try something different which past attending surgeons and faculty have really enjoyed? I invite you to Orlando to experience a meeting like no other – exciting, useful, intense and fun – the way education is supposed to be!"
Abstract: Descemet membrane endothelial keratoplasty (DMEK) is gaining popularity worldwide as a procedure to address corneal endothelial dysfunctions. Its perfect anatomical result improves outcomes and expedites visual recovery. This review addresses important aspects of safety, efficacy and patient selection.
Что "заставляет" Вас заниматься научными исследованиями?
Популярная пресса
Интересное видео
Клуб молодых офтальмологов

МОО "Глаукомное общество"

Экспертный совет по глаукоме

Диабет. Рекомендации

Глаукома. Рекомендации ICO

Новостная лента на Twitter
Новости зарубежной офтальмологии